Darzalex 1800 mg solution for injection


Solution for Injection
scheduling status
S4
registration number
57/26/0332
What Darzalex 1800 mg solution for injection contains
Daratumumab.
other ingredients
Recombinant human hyaluronidase (rHuPH20), L-histidine, L-histidine HCl monohydrate, L-methionine, polysorbate 20, sorbitol (E420), and water for injection.
Therapeutic classification
A 26 Cytostatic agents (L01FC01).
© 2026 SAHPRA. ALL RIGHTS RESERVED